Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

114 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Completed

LOW-PV Continuation

NCT06752941

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Fondazione IRCCS Policlinico San Matteo, Divisione Ematologia Pavia, Lombardy, Italy
  • Ospedale Borgo Roma, Divisione Ematologia Verona, Veneto, Italy
  • ASST Papa Giovanni XXIII, SC Ematologia Bergamo, Italy
  • Policlinico S. Orsola - Malpighi, UO Ematologia Bologna, Italy
View all 13 locations
View Trial Details
Completed

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

NCT02493530

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • Mays Cancer Center at University of Texas Health San Antonio San Antonio, Texas, United States
View Trial Details
Completed

A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)

NCT05558696

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • BRCR Global ( Site 0120) Plantation, Florida, United States
  • Hematology Oncology of the North Shore ( Site 0104) Skokie, Illinois, United States
  • University of Michigan Comprehensive Cancer Center ( Site 0008) Ann Arbor, Michigan, United States
  • Comprehensive Cancer Centers of Nevada - Peak ( Site 0118) Las Vegas, Nevada, United States
View all 17 locations
View Trial Details
Completed

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

NCT04629508

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +11 more
Locations
  • Tulane University New Orleans, Louisiana, United States
  • Rcca Md, Llc Bethesda, Maryland, United States
  • Midamerica Cancer Care Kansas City, Missouri, United States
  • New Jersey Hematology Oncology Associates Llc Brick, New Jersey, United States
View all 21 locations
View Trial Details
Completed

Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)

NCT04057040

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Mayo Clinic - Mayo Clinic Hospital Phoenix, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • Stanford University Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 16 locations
View Trial Details
Completed

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

NCT00588991

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Completed

The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV

NCT03003325

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • U.O. Ematologia, Ospedale Casa Sollievo della Sofferenza Istituto di Ricovero e Cura a Carattere Scientifico San Giovanni Rotondo, (FG) Puglia, Italy
  • U.O. Ematologia con Trapianto, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari Bari, Apulia, Italy
  • Azienda Ospedaliera Universitaria Federico II di Napoli Naples, Campania, Italy
  • Divisione Ematologia Policlinico S. Orsola - Malpighi Bologna, Emilia-Romagna, Italy
View all 23 locations
View Trial Details

Related conditions